Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04564183 · ClinicalTrials.gov registry record
Advancing Prevention of Pulmonary Fibrosis
A clinical trial of Pulmonary Fibrosis and IPF, sponsored by University of Colorado, Denver.
- Active
- Registry status
- 800
- Enrollment target
- 1
- Study location
NCT04564183: Active study of Pulmonary Fibrosis and IPF, sponsored by University of Colorado, Denver.
NCT04564183 is a study of Pulmonary Fibrosis and IPF that is active but no longer recruiting, run by University of Colorado, Denver. The registered enrollment target is 800 participants, roughly in line with the 853-participant average among 22 other Pulmonary Fibrosis trials with a reported enrollment target. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04564183, a study of Pulmonary Fibrosis and IPF, is active but no longer recruiting, sponsored by University of Colorado, Denver.
- ACTIVE NOT RECRUITING
- Registry status
- 800 participants
- Enrollment target
- 1
- Study location
Study Summary
This study plans to learn more about pulmonary fibrosis and how it develops. We want to determine if the disease can be detected early, before the lung is permanently scarred. This study will enroll participants who are not currently diagnosed with pulmonary fibrosis, but who have family members with pulmonary fibrosis. Because there is an increased risk within affected families, this cohort will allow us to learn how pulmonary fibrosis develops, and how the lungs change over time.
Primary Outcome
All subjects will be screened with a high resolution CT scan to identify early signs of lung fibrosis. CT scans will be evaluated by study radiologists.
Conditions Studied
Interventions
- OTHER Questionnaires
- OTHER Sample collection
- DIAGNOSTIC_TEST Pulmonary Function Test
- RADIATION High resolution CT scan of the chest
Study Locations (1)
Colorado
- University of Colorado Anschutz Medical Campus - Aurora
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 800 participants |
| Start Date | 2021-01-22 |
| Est. Completion | 2026-08-01 |
What the registry record for NCT04564183 still lists
NCT04564183 is an observational study that tracks outcomes without assigning an intervention. The registered 800 participants enrollment target is mid-sized for trials with a published cap, roughly in line with the 853-participant average among 22 other Pulmonary Fibrosis trials with a reported enrollment target.
The record links to 3 conditions, with Pulmonary Fibrosis appearing as the primary indexed condition, and to 4 interventions - of which Questionnaires is the first listed.
NCT04564183 reports a single indexed study location in Colorado.
Frequently Asked Questions
What is clinical trial NCT04564183 about?
NCT04564183 is a clinical study titled "Advancing Prevention of Pulmonary Fibrosis". This study plans to learn more about pulmonary fibrosis and how it develops. We want to determine if the disease can be detected early, before the lung is permanently scarred. This study will enroll participants who are not currently diagnosed with pulmonary fibrosis, but who have family members wi...
What is the current status of trial NCT04564183?
This trial is currently active not recruiting. The enrollment target is 800 participants. The study started on 2021-01-22. Estimated completion is 2026-08-01.
What conditions does trial NCT04564183 study?
This clinical trial studies the following conditions: Pulmonary Fibrosis, IPF, ILD.
What interventions are being tested in trial NCT04564183?
The interventions under investigation include: Questionnaires (OTHER), Sample collection (OTHER), Pulmonary Function Test (DIAGNOSTIC_TEST), High resolution CT scan of the chest (RADIATION).
Who is sponsoring clinical trial NCT04564183?
This trial is sponsored by University of Colorado, Denver, which has 1,283 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04564183 being conducted?
This trial has 1 study location across Colorado. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Pulmonary Fibrosis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04564183's enrollment target sits among peer trials
800 5th of 22 higher than 18 of 22 other Pulmonary Fibrosis trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Pulmonary Fibrosis trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Advanced Imaging for Pulmonary Fibrosis
RECRUITING · Phase 2
-
Pulmonary Fibrosis Foundation Community Registry
RECRUITING
-
Interstitial Lung Disease Research Unit Biobank
RECRUITING
-
FAPI PET for Lung Fibrosis
RECRUITING · Early Phase 1
-
Single Time Point Prediction as Earlier Diagnosis of Progressive Pulmonary Fibrosis
RECRUITING
-
Telehealth and Onsite Maintenance Exercise in Chronic Lung Disease
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00695214 · 800 participants · Phase 2
Drug-Induced Sleep Endoscopy for Upper Airway Evaluation in Obstructive Sleep Apnea
- NCT03048201 · 800 participants · NA
Physica System Total Knee Replacement Registry Study
- NCT03792659 · 800 participants
The EXPLORE MG Registry for Myasthenia Gravis
- NCT03819296 · 800 participants · Phase 1
Role of Gut Microbiome and Fecal Transplant on Medication-Induced GI Complications in Patients With Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI